search
Back to results

Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones

Primary Purpose

Choledocholithiasis, Large Common Bile Duct Stone

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
ERCP
Endoscopic Sphincterotomy
Large Balloon Dilatation of Oddi Sphincter
Stone extraction
Sponsored by
Société Française d'Endoscopie Digestive
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Choledocholithiasis focused on measuring Cholangiopancreatography, therapeutic strategy, Endoscopic Retrograde

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient with CBD stones with a smaller diameter ≥ 13mm on cholangiogram

Exclusion Criteria:

  • Active or history of acute pancreatitis
  • Presence of intrahepatic stones
  • History of Billroth II or roux-en-Y reconstruction
  • Coagulation disorder (partial thromboplastin time > 42 seconds, prothrombin time (Quick value) < 50% and platelet count of <50 000/mm3)
  • Current anticoagulation or clopidogrel treatment
  • Pregnancy
  • Inability to give informed consent

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    ESLBD

    CONV

    Arm Description

    Endoscopic Sphincterotomy plus Large Balloon Dilatation +/- lithotripsy ERCP with deep cancellation of BDS Endoscopic large sphincterotomy Large Balloon Dilatation of Oddi Sphincter: with the HERCULES, Cook 12, 15, 18 or 20 mm of diameter (adapted to stone diameter) Stone extraction with dormia basket or extraction balloon Mechanical Lithotripsy if needed

    Conventional treatment associating Endoscopic Sphincterotomy +/- Mechanical Lithotripsy (ES+/-LM) ERCP with deep cancellation of BDS Endoscopic large sphincterotomy Stone extraction with dormia basket or extraction balloon Mechanical Lithotripsy if needed

    Outcomes

    Primary Outcome Measures

    Success of common bile duct clearance in one session of ERCP (endoscopic retrograde cholangiopancreatography)

    Secondary Outcome Measures

    Number of patients with mild or severe BLEEDING (Morbidity) after ERCP
    Immediate complications were noted : bleeding : mild if blood transfusion not necessary, and severe if blood transfusion necessary Clinical data (pain, fever, vomiting...) are noted during first month Clinical examination and blood tests (Blood count, C reactive protein, lipase blood test, hepatic tests, creatininemia) were noted at the 30th day after procedure In case of bleeding suspected, a new ERCP was done Number of patients with bleeding and with any complication in both groups were noted and compared
    Number of patients with mild or severe ACUTE PANCREATITIS (Morbidity) after ERCP
    Immediate complications were noted : Acute pancreatitis : defined by the association of abdominal pain and lipase blood test > 3 N Severity of acute pancreatitis was evaluated on CT index, and on evolution data Clinical data (pain, fever, vomiting...) are noted during first month Clinical examination and blood tests (Blood count, C reactive protein, lipase blood test, hepatic tests, creatininemia) were noted at the 30th day after procedure Abdominal CT was performed in case of suspected acute pancreatitis Number of patients with Acute Pancreatitis and any complication in both groups were noted and compared
    Number of patients with PERFORATION (Morbidity of ERCP)
    Suspected on clinical data (pain, fever, vomiting...) and blood tests (Blood count, C reactive protein) noted during first day after ERCP: confirmed on CT Number of patients with perforation in both groups were noted and compared, and global morbidity in both groups were noted and compared
    Number of patients with post ERCP INFECTION as angiocholitis, cholecystitis or urine infection, septicemia (Morbidity of ERCP)
    Suspected on clinical data (pain, fever, vomiting...), blood tests (Blood count, C reactive protein, blood and urine cultures), noted during first day after ERCP, during 30th day and more if necessary in the meantime Abdominal US and CT were performed if necessary Number of patients with infection in both groups were noted and compared, and global morbidity in both groups were noted and compared
    GLOBAL MORBIDITY of ERCP (number of patients with bleeding and/or acute pancreatistis and/or perforation and/or infection)
    - Number of patients with any complication as bleeding, acute pancreatitis, perforation, infection (as angiocholitis, cholecystitis, urine infection or septicemia) happened in both groups during the first month after the procedure were noted and compared
    MORTALITY of ERCP
    - Number of death happened in both groups during the first month after the procedure were noted and compared
    Number of patients with recurrence of BDS
    Clinical data (pain, fever, vomiting...) are noted during first month Clinical examination and blood tests (Blood count, C reactive protein, lipase blood test, hepatic tests, creatininemia) were noted at the 30th day after procedure In case of recurrence BDS suspected, abdominal US and/or CT and/or MRI and/or EUS (Endoscopic Ultrasonography) were done, and if BDS was confirmed, a new ERCP was done Number of patients with recurrence of BDS in both groups in the first month after the procedure were noted and compared
    Length of procedure
    For each patient, time was noted at the beginning and at the end of ERCP
    Cost of procedure
    All the instrument used during ERCP (endoscopic retrograde cholangiopancreatography) for each patient were noted, and at the end of procedure cost of all instruments were recorded
    comparison of the frequency of mechanical lithotripsy of both groups
    In both groups mechanical lithotripsy can be performed in case of impossibility of stone extraction. The rate of lithotripsy performed in both groups were compared

    Full Information

    First Posted
    October 5, 2015
    Last Updated
    October 28, 2015
    Sponsor
    Société Française d'Endoscopie Digestive
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02592811
    Brief Title
    Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones
    Official Title
    Endoscopic Sphincterotomy Plus Large-Balloon Dilatation (ESLBD) Versus Conventional Endoscopic Treatment for Removal of Large Common Bile Duct Stones : A Prospective Comparative Multi Center Randomized Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2015
    Overall Recruitment Status
    Completed
    Study Start Date
    July 2010 (undefined)
    Primary Completion Date
    March 2015 (Actual)
    Study Completion Date
    March 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Société Française d'Endoscopie Digestive

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Bile duct stone extraction is impossible after endoscopic sphincterotomy (ES) alone in approximatively 10% of cases (mostly because of stones' size). Adjunction of a mechanical lithotripsy (ML) is well established to improve clearance of common bile duct (CBD) stones. Because of inconstant success, high cost, and length of procedure, an alternative method was proposed in 2003: endoscopic sphincterotomy plus large balloon dilatation (ESLBD). If the safety of ESLBD is accepted in all recent published studies, it remains controversial wether ESLBD is superior to conventional endoscopic treatment associating ES± ML for CBD stones. Procedure treatment and place of ESLBD in CBD stones therapeutic strategy is unclear. The purpose of this prospective comparative multi center randomized study is to evaluate the superiority or not of ESLBD on conventional treatment (ES±ML) for the treatment of large bile duct stone (≥13mm) after standard ES, and to propose a new CBD stones therapeutic strategy.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Choledocholithiasis, Large Common Bile Duct Stone
    Keywords
    Cholangiopancreatography, therapeutic strategy, Endoscopic Retrograde

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    150 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    ESLBD
    Arm Type
    Active Comparator
    Arm Description
    Endoscopic Sphincterotomy plus Large Balloon Dilatation +/- lithotripsy ERCP with deep cancellation of BDS Endoscopic large sphincterotomy Large Balloon Dilatation of Oddi Sphincter: with the HERCULES, Cook 12, 15, 18 or 20 mm of diameter (adapted to stone diameter) Stone extraction with dormia basket or extraction balloon Mechanical Lithotripsy if needed
    Arm Title
    CONV
    Arm Type
    Active Comparator
    Arm Description
    Conventional treatment associating Endoscopic Sphincterotomy +/- Mechanical Lithotripsy (ES+/-LM) ERCP with deep cancellation of BDS Endoscopic large sphincterotomy Stone extraction with dormia basket or extraction balloon Mechanical Lithotripsy if needed
    Intervention Type
    Procedure
    Intervention Name(s)
    ERCP
    Other Intervention Name(s)
    Cholangiogram with deep cannulation of CBD
    Intervention Description
    Common bile duct cannulation with a cannulation catheter
    Intervention Type
    Procedure
    Intervention Name(s)
    Endoscopic Sphincterotomy
    Other Intervention Name(s)
    ES
    Intervention Description
    Endoscopic large sphincterotomy
    Intervention Type
    Device
    Intervention Name(s)
    Large Balloon Dilatation of Oddi Sphincter
    Other Intervention Name(s)
    LBD, LBDS
    Intervention Description
    Large Balloon Dilatation : with the HERCULES, Cook 12, 15, 18 or 20 mm of diameter (adapted to stone diameter)
    Intervention Type
    Procedure
    Intervention Name(s)
    Stone extraction
    Intervention Description
    After dilatation, extraction of stones is done with dormia basket or extraction balloon and if not possible a mechanical lithotripsy is performed
    Primary Outcome Measure Information:
    Title
    Success of common bile duct clearance in one session of ERCP (endoscopic retrograde cholangiopancreatography)
    Time Frame
    1 month
    Secondary Outcome Measure Information:
    Title
    Number of patients with mild or severe BLEEDING (Morbidity) after ERCP
    Description
    Immediate complications were noted : bleeding : mild if blood transfusion not necessary, and severe if blood transfusion necessary Clinical data (pain, fever, vomiting...) are noted during first month Clinical examination and blood tests (Blood count, C reactive protein, lipase blood test, hepatic tests, creatininemia) were noted at the 30th day after procedure In case of bleeding suspected, a new ERCP was done Number of patients with bleeding and with any complication in both groups were noted and compared
    Time Frame
    1 month
    Title
    Number of patients with mild or severe ACUTE PANCREATITIS (Morbidity) after ERCP
    Description
    Immediate complications were noted : Acute pancreatitis : defined by the association of abdominal pain and lipase blood test > 3 N Severity of acute pancreatitis was evaluated on CT index, and on evolution data Clinical data (pain, fever, vomiting...) are noted during first month Clinical examination and blood tests (Blood count, C reactive protein, lipase blood test, hepatic tests, creatininemia) were noted at the 30th day after procedure Abdominal CT was performed in case of suspected acute pancreatitis Number of patients with Acute Pancreatitis and any complication in both groups were noted and compared
    Time Frame
    1 month
    Title
    Number of patients with PERFORATION (Morbidity of ERCP)
    Description
    Suspected on clinical data (pain, fever, vomiting...) and blood tests (Blood count, C reactive protein) noted during first day after ERCP: confirmed on CT Number of patients with perforation in both groups were noted and compared, and global morbidity in both groups were noted and compared
    Time Frame
    1 day
    Title
    Number of patients with post ERCP INFECTION as angiocholitis, cholecystitis or urine infection, septicemia (Morbidity of ERCP)
    Description
    Suspected on clinical data (pain, fever, vomiting...), blood tests (Blood count, C reactive protein, blood and urine cultures), noted during first day after ERCP, during 30th day and more if necessary in the meantime Abdominal US and CT were performed if necessary Number of patients with infection in both groups were noted and compared, and global morbidity in both groups were noted and compared
    Time Frame
    1 month
    Title
    GLOBAL MORBIDITY of ERCP (number of patients with bleeding and/or acute pancreatistis and/or perforation and/or infection)
    Description
    - Number of patients with any complication as bleeding, acute pancreatitis, perforation, infection (as angiocholitis, cholecystitis, urine infection or septicemia) happened in both groups during the first month after the procedure were noted and compared
    Time Frame
    1 month
    Title
    MORTALITY of ERCP
    Description
    - Number of death happened in both groups during the first month after the procedure were noted and compared
    Time Frame
    1 month
    Title
    Number of patients with recurrence of BDS
    Description
    Clinical data (pain, fever, vomiting...) are noted during first month Clinical examination and blood tests (Blood count, C reactive protein, lipase blood test, hepatic tests, creatininemia) were noted at the 30th day after procedure In case of recurrence BDS suspected, abdominal US and/or CT and/or MRI and/or EUS (Endoscopic Ultrasonography) were done, and if BDS was confirmed, a new ERCP was done Number of patients with recurrence of BDS in both groups in the first month after the procedure were noted and compared
    Time Frame
    1 month
    Title
    Length of procedure
    Description
    For each patient, time was noted at the beginning and at the end of ERCP
    Time Frame
    Day one
    Title
    Cost of procedure
    Description
    All the instrument used during ERCP (endoscopic retrograde cholangiopancreatography) for each patient were noted, and at the end of procedure cost of all instruments were recorded
    Time Frame
    Day one
    Title
    comparison of the frequency of mechanical lithotripsy of both groups
    Description
    In both groups mechanical lithotripsy can be performed in case of impossibility of stone extraction. The rate of lithotripsy performed in both groups were compared
    Time Frame
    Day one

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patient with CBD stones with a smaller diameter ≥ 13mm on cholangiogram Exclusion Criteria: Active or history of acute pancreatitis Presence of intrahepatic stones History of Billroth II or roux-en-Y reconstruction Coagulation disorder (partial thromboplastin time > 42 seconds, prothrombin time (Quick value) < 50% and platelet count of <50 000/mm3) Current anticoagulation or clopidogrel treatment Pregnancy Inability to give informed consent
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    David KARSENTI, MD
    Organizational Affiliation
    Société Française d'Endoscopie Digestive
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    28753698
    Citation
    Karsenti D, Coron E, Vanbiervliet G, Privat J, Kull E, Bichard P, Perrot B, Quentin V, Duriez A, Cholet F, Subtil C, Duchmann JC, Lefort C, Hudziak H, Koch S, Granval P, Lecleire S, Charachon A, Barange K, Cesbron EM, De Widerspach A, Le Baleur Y, Barthet M, Poincloux L. Complete endoscopic sphincterotomy with vs. without large-balloon dilation for the removal of large bile duct stones: randomized multicenter study. Endoscopy. 2017 Oct;49(10):968-976. doi: 10.1055/s-0043-114411. Epub 2017 Jul 28.
    Results Reference
    derived

    Learn more about this trial

    Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones

    We'll reach out to this number within 24 hrs